Contact us Observational Studies HOMESOLUTIONSREAL-WORLD EVIDENCE AND LATE PHASEOBSERVATIONAL STUDIES Helping you to see the big picture. Observational research can help us understand more about causal associations between treatments and outcomes and more about the world in general. These non-interventional studies have become valuable tools in health because they offer broad ways to answer real-world clinical research and product usage questions. However, they are notoriously challenging to implement. Several study designs fall within this category of research including: Cohort studies, including prospective patient registries Case-control studies, including retrospective chart reviews; and Database studies using electronic health records (EHR) or third-party databases Our global team of pharmacoepidemiologists, pharmacovigilance, regulatory, and research operations advisors are able to: Help you define the needs of your target audience(s) and to develop the best study design to meet your research objectives Define the optimal regulatory authority and ethics committee submission strategies in each country or region Implement a study management and resourcing model trained to collect the required data in the most efficient manner and to agreed-upon standards of quality Case Study: Metabolic disease observational study When a client needed support in a global observational study involving nearly 60,000 patients, Parexel combined its global infrastructure with localized support to accelerate start-up, meet recruitment goals early and reduce site management cost by 150%. Read more Enhance your Parexel experience! Visit our Preference Center to provide, view and edit your communication preferences, topics of interest, and contact information. Visit center Parexel Resource Center Browse the Parexel Resource Center for our latest content on clinical trial supplies, logistics, innovation, drug safety, cell & gene therapy, and more! Visit Resource Center We are always available for a conversation. Select Country Afghanistan Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Colombia Comoros Congo Costa Rica Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Isle of Man Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jersey Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kosovo Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Northern Mariana Islands Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States minor outlying islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (U.S.) Wallis and Futuna Islands Yemen Zambia Zimbabwe CORPORATE LINKS About Us News Events Careers Education Investigators My Preferences Global Locations SOLUTIONS Parexel Biotech Clinical Development Consulting Medical Affairs Real-World Evidence FSP STUDIES & VOLUNTEERS About Trials Participate in a Trial GLOBAL STUDY LOCATIONS Baltimore, US Los Angeles, US London, UK Berlin, DE 275 Grove St., Suite 101C, Newton, MA 02466 +1 617 454 9300 2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713 +1 919 544 3170 © 2000-2021. Parexel International Corporation. All Rights Reserved. Privacy Policy Terms of Service Modern Slavery Statement Act By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies